MaxCyte Announces Pricing of Upsized Offering and Approval to List on the Nasdaq Global Select MarketPRNewsWire • 07/30/21
MaxCyte Announces Public Filing of Registration Statement with SEC for a Proposed Nasdaq Dual ListingPRNewsWire • 07/12/21